U.S. markets open in 1 hour 50 minutes
  • S&P Futures

    3,635.75
    +3.00 (+0.08%)
     
  • Dow Futures

    29,979.00
    -19.00 (-0.06%)
     
  • Nasdaq Futures

    12,121.50
    +45.50 (+0.38%)
     
  • Russell 2000 Futures

    1,848.80
    -2.70 (-0.15%)
     
  • Crude Oil

    45.29
    +0.38 (+0.85%)
     
  • Gold

    1,811.10
    +6.50 (+0.36%)
     
  • Silver

    23.41
    +0.11 (+0.45%)
     
  • EUR/USD

    1.1891
    -0.0006 (-0.05%)
     
  • 10-Yr Bond

    0.8820
    0.0000 (0.00%)
     
  • Vix

    21.93
    -0.73 (-3.22%)
     
  • GBP/USD

    1.3345
    -0.0014 (-0.10%)
     
  • USD/JPY

    104.4580
    -0.0220 (-0.02%)
     
  • BTC-USD

    19,220.69
    -45.96 (-0.24%)
     
  • CMC Crypto 200

    381.37
    +11.62 (+3.14%)
     
  • FTSE 100

    6,390.91
    -41.26 (-0.64%)
     
  • Nikkei 225

    26,296.86
    +131.27 (+0.50%)
     

Five Prime Therapeutics: 3Q Earnings Snapshot

·1 min read

SOUTH SAN FRANCISCO, Calif. (AP) _ Five Prime Therapeutics Inc. (FPRX) on Tuesday reported a loss of $26.4 million in its third quarter.

The South San Francisco, California-based company said it had a loss of 74 cents per share.

The results did not meet Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 61 cents per share.

The biotech company that develops treatments targeting cancer and autoimmune diseases posted revenue of $2 million in the period, which also did not meet Street forecasts. Three analysts surveyed by Zacks expected $3.5 million.

In the final minutes of trading on Tuesday, the company's shares hit $4.81. A year ago, they were trading at $4.16.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FPRX at https://www.zacks.com/ap/FPRX